个人科研网厅 | | 帮助
高级检索
当前位置： 首页 > 详情页

Chinese Guideline on the Primary Prevention of Cardiovascular Diseases

| 认领 | 导出 | |

文献详情

资源类型：
WOS体系：

收录情况： ◇ 卓越：高起点新刊 ◇ ESCI ◇ 中华系列

作者：
Liu, Jing[1,5] * ; Sun, Yihong[2] ; Peng, Daoquan[3] ; Zhang, Yuqing[4] ; Gao, Runlin[4] ; Zhao, Dong[1] ; Wang, Ji-Guang[6] ; Ye, Ping[7,45] ; Guo, Yifang[8] ; Yang, Xinchun[9] ; Chen, Luyuan[10] ; Li, Jianjun[4] ; Cheng, Xiang[11] ; Bian, Huiping[12] ; Cai, Jun[4] ; Chen, Guiying[13] ; Chen, Hong[5] ; Chen, Jiyan[10] ; Chen, Xiaoping[2] ; Chen, Zhenyue[14] ; Chen, Luyuan[10] ; Dai, Ruozhu[15] ; Ding, Rongjing[5] ; Ding, Shifang[16] ; Dong, Xugang[17] ; Fan, Zhiqing[18] ; Feng, Yingqing[10] ; Fu, Xianghua[19] ; Gao, Runlin[4] ; Guo, Jianjun[20] ; Han, Yaling[21] ; Hou, Jingbo[22] ; Hu, Dayi[5] ; Huang, Kai[11,23] ; Ji, Linong[5] ; Jia, Shaobin[24] ; Jiang, Hong[25] ; Jing, Zhi-Cheng[26] ; Li, Liwen[10] ; Li, Chunjian[27] ; Li, Jianjun[4] ; Li, Ling[28] ; Li, Xiaodong[29] ; Li, Xinli[30] ; Li, Yi[21] ; Li, Yuming[31] ; Liang, Chun[32] ; Liu, Jing[1,5] ; Liu, Peiliang[33] ; Ma, Changsheng[1] ; Meng, Xiaoping[34] ; Ning, Guang[14] ; Ning, Yi[35] ; Qi, Xiaoyong[8] ; Qu, Peng[36] ; Shen, Yuqin[37] ; Shi, Xubo[38] ; Tang, Yida[39] ; Wang, Dongwei[40] ; Wang, Lemin[37] ; Wang, Shouli[41] ; Wang, Xiaozeng[21] ; Wu, Yongjian[4] ; Xiao, Dan[42] ; Xiao, Xinhua[26] ; Xu, Biao[43] ; Xu, Juntang[5] ; Yan, Chenghui[21] ; Yang, Lixia[44] ; Yang, Xinchun[9] ; Ye, Ping[7,45] ; Yu, Miao[26] ; Yu, Jinming[46] ; Yuan, Jinqing[4] ; Yuan, Zuyi[47] ; Zhang, Cuntai[48] ; Zhang, Jian[21] ; Zhang, Junjie[49] ; Zhang, Ruiyan[14] ; Zhang, Xiaofei[50] ; Zhang, Yaojun[51] ; Zhao, Wenhua[52] ; Zhou, Shenghua[3] ; Zhou, Yingsheng[1] ; Zhou, Yujie[1] ;
机构： [1]Capital Med Univ, Beijing Anzhen Hosp, Beijing, Peoples R China [2]China Japan Friendship Hosp, Beijing, Peoples R China [3]Cent South Univ, Xiangya Hosp 2, Changsha, Peoples R China [4]Chinese Acad Med Sci, Fuwai Hosp, Beijing, Peoples R China [5]Peking Univ Peoples Hosp, Beijing, Peoples R China [6]Shanghai Jiao Tong Univ, Ruijin Hosp, Shanghai Inst Hypertens, Sch Med, Shanghai, Peoples R China [7]Gen Hosp Chinese Peoples Liberat Army, Med Ctr 2, Nanjing, Peoples R China [8]Hebei Gen Hosp, Shijiazhuang, Hebei, Peoples R China [9]Capital Med Univ, Beijing Chaoyang Hosp, Beijing, Peoples R China [10]Guangdong Gen Hosp, Guangzhou, Peoples R China [11]Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Wuhan, Peoples R China [12]Qinghai Prov Cardiovasc & Cerebrovasc Dis Special, Xining, Peoples R China [13]Harbin Med Univ, Affiliated Hosp 1, Harbin, Peoples R China [14]Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Shanghai, Peoples R China [15]Fujian Med Univ, Quanzhou Hosp 1, Fuzhou, Peoples R China [16]Gen Hosp Cent Theatre Command, Nanjing, Peoples R China [17]Sun Yat Sen Univ, Affiliated Hosp 1, Guangzhou, Peoples R China [18]Daqing Oilfields Gen Hosp, Daqing, Peoples R China [19]Hebei Med Univ, Hosp 2, Shijiazhuang, Hebei, Peoples R China [20]Capital Inst Phys Educ, Beijing, Peoples R China [21]Gen Hosp Northern Theater Command, Shenyang, Peoples R China [22]Harbin Med Univ, Affiliated Hosp 2, Harbin, Peoples R China [23]Huazhong Univ Sci & Technol, Tongji Med Coll, Liyuan Cardiovasc Clin Ctr, Wuhan, Peoples R China [24]Gen Hosp Ningxia Med Univ, Yinchuan, Ningxia, Peoples R China [25]Peoples Hosp Wuhan Univ, Wuhan, Peoples R China [26]Chinese Acad Med Sci, Peking Union Med Coll Hosp, Beijing, Peoples R China [27]Jiangsu Prov Hosp, Nanjing, Peoples R China [28]Zhengzhou Univ, Affiliated Hosp 1, Zhengzhou, Peoples R China [29]China Med Univ, Shengjing Hosp, Shenyang, Peoples R China [30]Nanjing Med Univ, Affiliated Hosp 1, Nanjing, Peoples R China [31]Teda Int Cardiovasc Hosp, Tianjin, Peoples R China [32]Shanghai Changzheng Hosp, Shanghai, Peoples R China [33]Liaoning Jinqiu Hosp, Shenyang, Peoples R China [34]Affiliated Hosp Changchun Univ Chinese Med, Changchun, Peoples R China [35]Peking Univ, Hlth Sci Ctr, Meinian Inst Publ Hlth, Beijing, Peoples R China [36]Dalian Med Univ, Affiliated Hosp 2, Dalian, Peoples R China [37]Tongji Univ, Tongji Hosp, Shanghai, Peoples R China [38]Capital Med Univ, Beijing Tongren Hosp, Beijing, Peoples R China [39]Peking Univ Third Hosp, Beijing, Peoples R China [40]Zhengzhou Cent Hosp, Zhengzhou, Peoples R China [41]Peoples Liberat Army Strateg Support Force Charac, Beijing, Peoples R China [42]China Japan Friendship Hosp, Natl Resp Med Ctr, Tobacco Med & Tobacco Cessat Ctr, Beijing, Peoples R China [43]Affiliated Hosp Nanjing Univ, Nanjing Drum Tower Hosp, Med Sch, Nanjing, Peoples R China [44]920 Hosp Joint Logist Support Force Chinese Peopl, Kunming, Yunnan, Peoples R China [45]Chinese Peoples Liberat Army Gen Hosp, Med Ctr 2, Nanjing, Peoples R China [46]Fudan Univ, Sch Publ Hlth, Shanghai, Peoples R China [47]Xi An Jiao Tong Univ, Affiliated Hosp 1, Xian, Peoples R China [48]Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Wuhan, Peoples R China [49]Nanjing First Hosp, Nanjing, Peoples R China [50]Tsinghua Univ, Beijing Tsinghua Changgung Hosp, Beijing, Peoples R China [51]Xuzhou Third Peoples Hosp, Xuzhou, Jiangsu, Peoples R China [52]Chinese Ctr Dis Control & Prevent, Natl Inst Nutr & Hlth, Beijing, Peoples R China
出处：
DOI： 10.1097/CD9.0000000000000025
ISSN：

关键词： Cardiovascular disease Primary prevention Guideline

摘要：
Cardiovascular disease is the leading cause of mortality in China. Primary prevention of cardiovascular disease with a focus on lifestyle intervention and risk factor control has been shown to effectively delay or prevent the occurrence of cardiovascular events. To promote a healthy lifestyle and enhance the detection, diagnosis, and treatment of cardiovascular risk factors such as hypertension, dyslipidemia, and diabetes, and to improve the overall capacity of primary prevention of cardiovascular disease, the Chinese Society of Cardiology of Chinese Medical Association has collaborated with multiple societies to summarize and evaluate the latest evidence with reference to relevant guidelines and subsequently to develop recommendations for primary cardiovascular disease prevention in Chinese adults. The guideline consists of 10 sections: introduction, methodology for developing the guideline, epidemiology of cardiovascular disease in China and challenges in primary prevention, general recommendations for primary prevention, assessment of cardiovascular risk, lifestyle intervention, blood pressure control, lipid management, management of type 2 diabetes, and use of aspirin. The promulgation and implementation of this guideline will play a key role in promoting the practice of primary prevention for cardiovascular disease in China.

语种：
外文
被引次数：
WOS：
中科院(CAS)分区：
出版当年[2020]版：
无
最新[2025]版：
大类 | 4 区 医学
小类 | 4 区 心脏和心血管系统
JCR分区：
出版当年[2019]版：
无
最新[2024]版：
Q4 CARDIAC & CARDIOVASCULAR SYSTEMS

影响因子： 最新[2024版] 最新五年平均 出版当年[2019版] 出版当年五年平均 出版前一年[2018版]

第一作者：
第一作者机构： [1]Capital Med Univ, Beijing Anzhen Hosp, Beijing, Peoples R China [5]Peking Univ Peoples Hosp, Beijing, Peoples R China
通讯作者：
推荐引用方式(GB/T 7714)：
Liu Jing,Sun Yihong,Peng Daoquan,et al.Chinese Guideline on the Primary Prevention of Cardiovascular Diseases[J].CARDIOLOGY DISCOVERY.2021,1(2):70-104.doi:10.1097/CD9.0000000000000025.
APA：
Liu, Jing,Sun, Yihong,Peng, Daoquan,Zhang, Yuqing,Gao, Runlin...&Zhou, Yujie.(2021).Chinese Guideline on the Primary Prevention of Cardiovascular Diseases.CARDIOLOGY DISCOVERY,1,(2)
MLA：
Liu, Jing,et al."Chinese Guideline on the Primary Prevention of Cardiovascular Diseases".CARDIOLOGY DISCOVERY 1..2(2021):70-104

相关文献

[1]中国女性心血管疾病预防专家共识 [2]阿司匹林在动脉粥样硬化性心血管疾病中的临床应用:中国专家共识(2016) [3]阿司匹林在动脉粥样硬化性心血管疾病中的临床应用:中国专家共识(2016) [4]阿司匹林在动脉粥样硬化性心血管疾病中的临床应用:中国专家共识(2016) [5]阿司匹林在动脉粥样硬化性心血管疾病一级预防中的研究进展 [6]中国心血管病一级预防指南 [7]Chronic Kidney Disease, All-Cause Mortality and Cardiovascular Mortality Among Chinese Patients with Established Cardiovascular Disease [8]1型糖尿病自身抗原胰岛素瘤相关蛋白2真核表达系统的构建和鉴定 [9]中国血脂管理指南(基层版2024年) [10]中国血脂管理指南（基层版2024年）

资源点击量：28499 今日访问量：0 总访问量：1584 更新日期：2025-09-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学附属北京同仁医院 技术支持：重庆聚合科技有限公司 地址：北京市东城区东交民巷1号(100730)